Doctors, drugmakers seeking reconciliation

Published: 2013-03-04 07:00:00

Updated: 2013-03-04 07:00:00

A clash between a group representing doctors and pharmaceutical companies that began last December shows a sign of abating as either side is willing to back down.

In a regular meeting of the Korea Pharmaceutical Manufacturers Association on Wednesday, Roh Hwan-kyu, the president of the Korean ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK